NEUROMYELITIS OPTICA SPECTRUM DISORDER

This study is testing whether the drug MIL62 can safely prevent relapses in adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves. Researchers will measure how long it takes for participants to have their first new attack wh…

This study follows people with NMOSD, a rare autoimmune disorder, who are taking or stopping the drug inebilizumab. Researchers want to understand how long-term treatment affects the immune system and how quickly it recovers after stopping the medication. They will monitor 32 par…

This study is testing whether a new device called MR-C-014 is safe and acceptable for people with NMOSD who have trouble walking. The device uses rhythmic music and foot sensors to try to improve walking patterns during at-home sessions. About 30 participants will use the device …

This study is creating a large registry of 800+ patients with neuromyelitis optica spectrum disorder (NMOSD) to better understand how the disease progresses over time and how treatments work in real-world settings. Researchers will track patients' experiences, treatments, and qua…

This study aims to understand the biological causes of rare, inflammatory nerve disorders like Neuromyelitis Optica and Transverse Myelitis. Researchers will follow 150 patients over time, collecting health data, questionnaires, and blood samples. The goal is to learn why treatme…